Intravascular Ultrasound Is an Effective Tool for Predicting Histopathology-Confirmed Evidence of Adventitial Injury Following Directional Atherectomy for the Treatment of Peripheral Artery Disease
Restricted accessLetterFirst published online August, 2016
Intravascular Ultrasound Is an Effective Tool for Predicting Histopathology-Confirmed Evidence of Adventitial Injury Following Directional Atherectomy for the Treatment of Peripheral Artery Disease
CriquiMHAboyansV. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509–1526.
2.
TarriconeAAliZRajamanickamA. Histopathological evidence of adventitial or medial injury is a strong predictor of restenosis during directional atherectomy for peripheral artery disease. J Endovasc Ther. 2015;22:712–715.
3.
BuckleyCJArkoFRLeeS. Intravascular ultrasound scanning improves long-term patency of iliac lesions treated with balloon angioplasty and primary stenting. J Vasc Surg. 2002;35:316–323.
4.
MoriSHiranoKNakanoM. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis. J Endovasc Ther. 2015;22:341–349.
5.
RastanASixtSSchwarzwälderU. Initial experience with directed laser atherectomy using the Clirpath Photoablation Atherectomy System and Bias sheath in superficial femoral artery lesions. J Endovasc Ther. 2007;14:365–373.
6.
RamaiahVGammonRKieszS. Midterm outcomes from the TALON registry: treating peripherals with SilverHawk: outcomes collection. J Endovasc Ther. 2006;13:592–602.
7.
RastanAMcKinseyJFGarciaLA; DEFINITIVE LE Investigators. One-year outcomes following directional atherectomy of infrapopliteal artery lesions: subgroup results of the prospective, multicenter DEFINITIVE LE trial. J Endovasc Ther. 2015;22:839–846.
8.
McKinseyJFZellerTRocha-SinghKJ; DEFINITIVE LE Investigators. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv. 2014;7:923–933.
9.
MarmagkiolisKHakeemAChoksiN. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty. Catheter Cardiovasc Interv. 2014;84:555–564.
10.
GallagherKAMeltzerAJRavinRA. Endovascular management as first therapy for chronic total occlusion of the lower extremity arteries: comparison of balloon angioplasty, stenting, and directional atherectomy. J Endovasc Ther. 2011;18:624–637.
11.
ZellerTSixtSSchwarzwalderU. Two-year results after directional atherectomy of infrapopliteal arteries with the SilverHawk device. J Endovasc Ther. 2007;14:232–240.
12.
StavroulakisKBisdasTTorselloG. Combined directional atherectomy and drug-eluting balloon angioplasty for isolated popliteal artery lesions in patients with peripheral artery disease. J Endovasc Ther. 2015;22:847–852.
13.
CioppaAStabileEPopusoiG. Combined treatment of heavy calcified femoropopliteal lesions using directional atherectomy and a paclitaxel coated balloon: one year single centre clinical results. Cardiovasc Revasc Med. 2012;13:219–223.
14.
LichtenbergMK. Debulking plus drug-coated balloon combination as revascularization strategy for complex femoropopliteal lesions. a new standard technique? [letter]J Endovasc Ther. 2016;23:396–398.
